This site may require a log-in in the near future. We are constantly being swamped by AI agents. If they continue to take down the site, we will be changing to requiring logins to access any item.

Kitasatosporales: NCBI 85011, [order]

Back to details

| "Streptomycetales" Kampfer 2012| Streptomycetales| Streptomycetes| Streptomycetineae| Streptomycineae| Streptomycineae Rainey et al. 1997 emend. Zhi et al. 2009

  1. Butyrate Production: Butyricicoccus pullicaecorum, like its name suggests, is likely involved in the production of butyrate, a short-chain fatty acid. Butyrate is known to be beneficial for gut health as it serves as an energy source for the cells lining the colon and has anti-inflammatory properties.

  2. Gut Microbiota Balance: Maintaining a balanced and diverse gut microbiota is crucial for overall health. Some bacteria, including those that produce butyrate like Butyricicoccus pullicaecorum, contribute to this balance and are associated with positive effects on gut function.

  3. Potential Probiotic Properties: Certain bacteria in the gut, including those that produce short-chain fatty acids like butyrate, are considered to have potential probiotic properties. Probiotics are live microorganisms that, when administered in adequate amounts, confer health benefits to the host.

Other Sources for more information:

Legend

Kitasatosporales impacts on other bacteria of the same rank

R2SlopeTax NameParent Chart
0.26272508502006530.5654692053794861GemmatimonadalesParent Taxa
0.25171381235122680.6159834861755371HypocrealesParent Taxa

Other bacteria of the same rank impacting Kitasatosporales

R2SlopeTax NameParent Chart

Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.

Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served.   Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 Β§β€―1030, CETS No.185, CFAA   Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license.   Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models.   Inventions /Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]